Breast cancer missed at screening; hindsight or mistakes?

被引:7
作者
Hovda, Tone [1 ]
Larsen, Marthe [2 ]
Romundstad, Linda [3 ]
Sahlberg, Kristine Kleivi [4 ,5 ]
Hofvind, Solveig [2 ,6 ]
机构
[1] Vestre Viken Hosp Trust, Dept Radiol, POB 800, N-3004 Drammen, Norway
[2] Canc Registry Norway, Sect Breast Canc Screening, Oslo, Norway
[3] Vestre Viken Hosp Trust, Dept Radiol, Drammen, Norway
[4] Vestre Viken Hosp Trust, Dept Res & Innovat, Drammen, Norway
[5] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway
[6] Arctic Univ Norway, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway
关键词
Breast; Neoplasms; Mass screening; Mammography; Female; MAMMOGRAPHY; RISK;
D O I
10.1016/j.ejrad.2023.110913
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To investigate radiologists' interpretation scores of screening mammograms prior to diagnosis of screen -detected and interval breast cancers retrospectively classified as missed or true negative.Methods: We included data on radiologists' interpretation scores at screening prior to diagnosis for 1223 screen -detected and 1007 interval cancer cases classified as missed or true negative in an informed consensus-based review. All prior screening examinations were independently scored 1-5 by two radiologists; score 1 by both was considered concordant negative, score & GE; 2 by one radiologist discordant, and score & GE; 2 by both concordant positive. We analyzed associations between interpretation, review categories, mammographic features and his-topathological findings using descriptive statistics and logistic regression.Results: Among screen-detected cancers, 31% of missed and 10% of true negative cancers had discordant or concordant positive interpretation at prior screening. The corresponding percentages for interval cancer were 21% and 8%. Age-adjusted odds ratio (OR) and 95% confidence interval (CI) for missed screen-detected cancer was 3.8 (95% CI: 2.6-5.4) after discordant and 5.5 (95% CI: 3.2-9.5) after concordant positive interpretation, using concordant negative as reference. Corresponding ORs for missed interval cancer were 3.0 (95% CI: 2.0-4.5) for discordant and 6.3 (95% CI: 2.3-17.5) for concordant positive interpretation. Asymmetry was the dominating mammographic feature at prior screening for all, except concordant positive screen-detected cancers where a mass dominated. Histopathological characteristics did not vary statistically with interpretation.Conclusions: Most cancers were interpreted negatively at screening prior to diagnosis. Increased risk for missed screen-detected or interval cancer was observed after positive interpretation at prior screening.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Impact of Breast Ultrasound Screening in Gynecological Practice
    Madjar, H.
    Becker, S.
    Doubek, K.
    Horchler, T.
    Mendoza, M.
    Moisidis-Tesch, C.
    Naether, B.
    Niebling, K.
    Proels, U.
    Schardt, A. -R.
    Ulrich, S.
    Zahn, U.
    [J]. ULTRASCHALL IN DER MEDIZIN, 2010, 31 (03): : 289 - 295
  • [32] Digital breast tomosynthesis in breast cancer screening: an ethical perspective
    Rosenqvist, Simon
    Brannmark, Johan
    Dustler, Magnus
    [J]. INSIGHTS INTO IMAGING, 2024, 15 (01):
  • [33] Breast MRI Screening of Women With a Personal History of Breast Cancer
    Brennan, Sandra
    Liberman, Laura
    Dershaw, D. David
    Morris, Elizabeth
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (02) : 510 - 516
  • [34] Conformable Ultrasound Breast Patch - The Future of Breast Cancer Screening?
    Giannakou, Andreas
    Dagdeviren, Canan
    Ozmen, Tolga
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2025, 21 (01) : 90 - 92
  • [35] Initial interpretation scores of screening mammograms and cancer detection in BreastScreen Norway
    Hovda, Tone
    Sagstad, Silje
    Moshina, Nataliia
    Vigeland, Einar
    Hofvind, Solveig
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2024, 179
  • [36] Breast cancer screening outcomes among Mexican-origin Hispanic women participating in a breast cancer screening program
    Winters, Stella
    Alomari, Adam
    Shokar, Gurjeet
    Martin, Charmaine
    Dwivedi, Alok
    Shokar, Navkiran K.
    [J]. PREVENTIVE MEDICINE REPORTS, 2021, 24
  • [37] Screening for Breast Cancer
    Narayan, Anand K.
    Lee, Christoph, I
    Lehman, Constance D.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2020, 104 (06) : 1007 - +
  • [38] Breast Cancer Screening in Korean Women: Report of the National Cancer Screening Program in 2008
    Oh, Dong Kwan
    Shim, Jung Im
    Han, Mia
    Kim, Yeonju
    Lee, Hoo-Yeon
    Jun, Jae Kwan
    Choi, Kui Sun
    Park, Eun-Cheol
    [J]. JOURNAL OF BREAST CANCER, 2010, 13 (03) : 299 - 304
  • [39] Breast cancer screening
    Houdebine, S.
    Doutriaux, I.
    Geffroy, D.
    Labbe, C.
    Nenciu, D.
    Meingan, P.
    Ricaud, M.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2014, 38 (05): : 283 - 292
  • [40] Screening for Breast Cancer
    Niell, Bethany L.
    Freer, Phoebe E.
    Weinfurtner, Robert Jared
    Arleo, Elizabeth Kagan
    Drukteinis, Jennifer S.
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2017, 55 (06) : 1145 - +